MALVERN, Pa., Sept. 26, 2022 (GLOBE NEWSWIRE) --  Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced upgrades today to the TrakStar® platform that will offer all NeuroStar® providers a more turnkey patient management experience.   Continuing Neuronetics’ commitment to innovation, this release represents the third TrakStar upgrade in 2022.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.